Astera Labs, Inc.

As of June 30, 2026, Astera Labs, Inc. Shs carries a market capitalization of 122.38T, placing it among publicly traded companies globally. Its enterprise value stands at 120.52T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Astera Labs, Inc. Shs's next confirmed earnings release is scheduled for November 3, 2026.

As of June 30, 2026, Astera Labs, Inc. Shs has 7.11B shares outstanding.

As of June 30, 2026, Astera Labs, Inc. Shs trades at a trailing price-to-earnings ratio of 218.79. The price-to-sales ratio is 67.26, and the price-to-book ratio stands at 47.80.

As of June 30, 2026, Astera Labs, Inc. Shs trades at an EV/EBITDA multiple of 284.66 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 67.59 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 297.11 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 120.52T versus a market cap of 122.38T, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Astera Labs, Inc. Shs maintains a current ratio of 10.05, meaning it holds 10.1x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Astera Labs, Inc. Shs posted a return on equity (ROE) of 25.83, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 23.07, measuring how efficiently the asset base is converted into earnings. The company generates approximately 2.63B in revenue per employee across its workforce of 677.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.47 indicates how many times Astera Labs, Inc. Shs sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Astera Labs, Inc. Shs recorded an income tax benefit of -70.43B rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 477.71B, leaving 548.14B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

These figures are as of the close on October 22, 2026. The 50-day moving average sits at 11,337.00, while the 200-day moving average is 8,844.24.

Over the twelve months ended June 30, 2026, Astera Labs, Inc. Shs generated 1.78T in revenue and converted that into 548.14B in net income, yielding earnings per share of 73.69. EBITDA reached 423.38B, while operating income came in at 405.66B.

These figures are as of June 30, 2026. Total book value stands at 2.56T, with working capital of 2.21T providing operational flexibility.

Astera Labs, Inc. Shs produced 498.03B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -87.58B in capital expenditures, free cash flow totaled 410.45B - equivalent to 58.93 per share.

Over the twelve months ended June 30, 2026, Astera Labs, Inc. Shs posted a gross margin of 75.13, reflecting its pricing power and cost economics. The operating margin of 22.75 and net profit margin of 30.74 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 0.32, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -0.01, meaning Astera Labs, Inc. Shs raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Astera Labs, Inc. Shs has an Altman Z-Score of 242.81, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.